Mathews Open Access Journals follow certain ethical standards to make sure high-quality scientific publications, to attain public confidence in scientific findings.
Plagiarism/ Duplicate Submission: Mathews Open Access Journals firmly encourages original manuscripts and must not use the words, figures, or ideas of others without attribution. All sources must be cited at the point they are used, and reuse of wording must be limited and be attributed or quoted in the text. The content should not be submitted/ published elsewhere with other publishing groups. Our quality control teams check for the plagiarism through software to detect the overlapping of content and similar text in submitted manuscripts. Manuscripts that are found to have been plagiarized from a manuscript by other authors, whether published or unpublished, will be rejected and the authors may incur sanctions. Any published articles may need to be corrected or retracted.
Data Fabrication and Falsification: If the submitted manuscripts are found to have either fabricated or falsified research work, i.e. methods, experimental results, including the manipulation of images will be immediately rejected.
Conflicts of Interest: Authors must declare all potential interests in a ‘Conflicts of interest’ section, which should explain why the interest may be a conflict. If there are none, the authors should state “The author(s) declare(s) that there are no conflicts of interest regarding the publication of this paper.” Submitting authors are responsible for coauthors declaring their interests.
Human and Animal Rights: Ethical clearance documents need to be provided if applicable. The work involving animal models and human volunteers need to submit the necessary statements.
In the above publication ethical cases if the violations are found, the editorial office is authorized to take action accordingly.
Published : 24th May 2024
Authors : Usama AA Sharaf El Din1,*, Mona M Salem2, Dina O Abdulazim3
Citation : Sharaf El Din UAA, et al. (2024). Sodium Glucose Co-Transporters Inhibitors as Better Alternative to Immunosuppressive Drugs in Management of Chronic Glomerulonephritis. Mathews J Urol Nephrol. 6(2):19.
Published : 22nd May 2024
Authors : Yassine Larrache, Mahmoud Alafifi*, Saleh Nedjim, Amine Moataz, Mohamed Dakir, Adil Debbagh, Rachid Aboutaieb
Citation : Larrache Y, et al. (2024). Urological Emergencies: An In-Depth Analysis of Incidence, Etiologies, and Therapeutic Approaches. Mathews J Urol Nephrol. 6(2):22.
Published : 21st May 2024
Authors : Doumer Abderrahmane, Alafifi Mahmoud, Safieddine Mehdi*, Moataz Amine, Dakir Mohamed, Debbagh Adil, Aboutaieb Rachid
Citation : Abderrahmane D, et al. (2024). Managing of Pyonephrosis: About 42 Cases. Mathews J Urol Nephrol. 6(2):21.
Published : 06th May 2024
Authors : Doumer Abderrahmane1,2, Hannaoui Ali1,2,*, Moataz Amine1,2, Dakir Mohamed1,2, Debbagh Adil1,2, Aboutaieb Rachid1,2
Citation : Abderrahmane D, et al. (2024). Intradiverticular Bladder Tumours Challenges and Outcomes: About 28 Cases. Mathews J Urol Nephrol. 6(2):20.
Published : 17th April 2024
Authors : Yassine Daghdagh, El Mostapha Abdi, Mahmoud Alafifi*, Anas Tmiri, Mouad Elbade, Amine Moataz, Mohamed Dakir, Adil Debbagh, Rachid Aboutaieb
Citation : Al-Affifi M, et al. (2024). Erectile Dysfunction: Epidemiological and Clinical Case Series Profile at the Ibn Rochd University Hospital in Casablanca. Mathews J Urol Nephrol. 6(1):18.
Published : 16th April 2024
Authors : Mahmoud Alafifi*, Abderrahmane Doumer, Hamza Ait Mahanna, Reda Safwate, Adil Kbiro, Amine Moataz, Mohamed Dakir, Adil Debbagh, Rachid Aboutaieb
Citation : Al-Affifi M, et al. (2024). Evaluating Renal Tumors: A Comprehensive Review of Risk Factors, Clinical Presentations, and Prognostic Histology in 80 Patients. Mathews J Urol Nephrol. 6(1):17.